High incidence ofPneumocystis jiroveciipneumonia in patients receiving biweekly rituximab and cyclophosphamide, adriamycin, vincristine, and prednisone
High incidence ofPneumocystis jiroveciipneumonia in patients receiving biweekly rituximab and cyclophosphamide, adriamycin, vincristine, and prednisone
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search